Kedrion Biopharma, commonly referred to as Kedrion, is a leading global player in the biopharmaceutical industry, headquartered in Italy. Founded in 2001, the company has established a strong presence in major operational regions, including Europe and North America, focusing on the development and production of human plasma-derived therapies. Kedrion's core offerings include immunoglobulins, clotting factors, and albumin, which are essential for treating various medical conditions. What sets Kedrion apart is its commitment to quality and innovation, ensuring that its products meet the highest safety standards. With a robust market position, Kedrion has achieved significant milestones, including expanding its product portfolio and enhancing its global distribution network, solidifying its reputation as a trusted provider in the biopharmaceutical sector.
How does Kedrion's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Kedrion's score of 27 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Kedrion reported total carbon emissions of approximately 30,122,000 kg CO2e from Scope 1 and about 35,982,000 kg CO2e from Scope 2. This represents a significant increase in emissions compared to 2021, where Scope 1 emissions were about 16,894,000 kg CO2e and Scope 2 emissions were approximately 25,581,000 kg CO2e. The data indicates a trend of rising emissions over the years, with 2020 figures showing Scope 1 emissions at about 32,736,000 kg CO2e and Scope 2 at around 21,143,000 kg CO2e. Kedrion's emissions data is cascaded from its parent company, Kedrion S.p.A., reflecting its current subsidiary status. However, there are no specific reduction targets or climate pledges documented for Kedrion, nor are there any reported initiatives under the Science Based Targets initiative (SBTi) or other climate frameworks. The absence of Scope 3 emissions data suggests a potential area for future reporting and improvement. Overall, while Kedrion has made strides in emissions reporting, the lack of reduction commitments highlights an opportunity for enhanced climate action and transparency in their sustainability efforts.
Access structured emissions data, company-specific emission factors, and source documents
2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|
Scope 1 | 2,421 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 21 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | - | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kedrion is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.